Liposomes to target peripheral neurons and Schwann cells.

by Sooyeon Lee, Ana Tari Ashizawa, Kwang Sik Kim, Darin J Falk, Lucia Notterpek
Published 2013-01-01

A scalable method for the production of high-titer and high-quality adeno-associated type 9 vectors using the HSV platform

by Laura Adamson-Small, Mark Potter, Darin J Falk, Brian Cleaver, Barry J Byrne, Nathalie Clément
Published 2016-01-01

13C/31P MRS Metabolic Biomarkers of Disease Progression and Response to AAV Delivery of hGAA in a Mouse Model of Pompe Disease

by Celine Baligand, Adrian G. Todd, Brittany Lee-McMullen, Ravneet S. Vohra, Barry J. Byrne, Darin J. Falk, Glenn A. Walter
Published 2017-12-01

Rapamycin improves peripheral nerve myelination while it fails to benefit neuromuscular performance in neuropathic mice

by Jessica Nicks, Sooyeon Lee, Andrew Harris, Darin J. Falk, Adrian G. Todd, Karla Arredondo, William A. Dunn, Jr., Lucia Notterpek
Published 2014-10-01

Comparative impact of AAV and enzyme replacement therapy on respiratory and cardiac function in adult Pompe mice

by Darin J Falk, Meghan S Soustek, Adrian Gary Todd, Cathryn S Mah, Denise A Cloutier, Jeffry S Kelley, Nathalie Clement, David D Fuller, Barry J Byrne
Published 2015-01-01

Hypoglossal neuropathology and respiratory activity in Pompe mice

by Kun-Ze eLee, Kai eQiu, Milapjit S Sandhu, Mai K Elmallah, Darin J Falk, Michael A Lane, Paul J Reier, Barry J Byrne, David D Fuller
Published 2011-06-01

AAV Gene Therapy Utilizing Glycosylation-Independent Lysosomal Targeting Tagged GAA in the Hypoglossal Motor System of Pompe Mice

by Brendan M. Doyle, Sara M.F. Turner, Michael D. Sunshine, Phillip A. Doerfler, Amy E. Poirier, Lauren A. Vaught, Marda L. Jorgensen, Darin J. Falk, Barry J. Byrne, David D. Fuller
Published 2019-12-01